Pulse End Period Cash Flow vs Capital Expenditures Analysis

PLSE Stock

USD 19.63 1.84 10.34%

Pulse Biosciences financial indicator trend analysis is much more than just breaking down Pulse Biosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pulse Biosciences is a good investment. Please check the relationship between Pulse Biosciences End Period Cash Flow and its Capital Expenditures accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulse Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.

End Period Cash Flow vs Capital Expenditures

End Period Cash Flow vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pulse Biosciences End Period Cash Flow account and Capital Expenditures. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Pulse Biosciences' End Period Cash Flow and Capital Expenditures is -0.21. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Pulse Biosciences, assuming nothing else is changed. The correlation between historical values of Pulse Biosciences' End Period Cash Flow and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Pulse Biosciences are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of End Period Cash Flow i.e., Pulse Biosciences' End Period Cash Flow and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

-0.21

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

End Period Cash Flow

Capital Expenditures

Capital Expenditures are funds used by Pulse Biosciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Pulse Biosciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most indicators from Pulse Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pulse Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulse Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.The current year's Enterprise Value is expected to grow to about 26.4 M, whereas Selling General Administrative is forecasted to decline to about 14.7 M.

	2022	2023	2024	2025 (projected)
Other Operating Expenses	58.8M	43.6M	50.1M	41.9M
Depreciation And Amortization	1.4M	1.2M	1.4M	1.1M

Other Operating Expenses Depreciation And Amortization

Pulse Biosciences fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets
Total Assets		0.74	0.78	0.53	-0.85	0.89	0.73	-0.71	-0.4	-0.8	0.79	0.85	0.56	0.72	0.07	0.98	-0.26	0.9	0.72	0.57	0.51	0.78	0.65	0.72	0.99	-0.85
Other Current Liab	0.74		0.99	0.43	-0.9	0.56	0.96	-0.71	-0.3	-0.86	0.94	0.58	0.89	0.89	0.51	0.62	-0.26	0.95	0.75	0.31	0.79	0.81	0.45	0.91	0.67	-0.89
Total Current Liabilities	0.78	0.99		0.37	-0.91	0.57	0.98	-0.7	-0.26	-0.89	0.96	0.64	0.91	0.91	0.42	0.66	-0.26	0.95	0.76	0.42	0.81	0.84	0.55	0.92	0.71	-0.91
Total Stockholder Equity	0.53	0.43	0.37		-0.47	0.79	0.22	-0.48	-0.82	-0.29	0.46	0.36	0.08	0.28	-0.05	0.55	-0.23	0.5	0.39	-0.39	0.28	0.4	-0.3	0.3	0.56	-0.41
Other Liab	-0.85	-0.9	-0.91	-0.47		-0.7	-0.88	0.7	0.44	0.88	-0.92	-0.78	-0.79	-0.9	-0.31	-0.77	0.4	-0.93	-0.81	-0.42	-0.66	-0.87	-0.54	-0.89	-0.8	0.92
Net Tangible Assets	0.89	0.56	0.57	0.79	-0.7		0.46	-0.68	-0.59	-0.53	0.65	0.68	0.28	0.49	-0.04	0.91	-0.19	0.74	0.51	0.22	0.41	0.57	0.3	0.46	0.92	-0.64
Property Plant And Equipment Net	0.73	0.96	0.98	0.22	-0.88	0.46		-0.64	-0.1	-0.88	0.93	0.58	0.96	0.95	0.49	0.6	-0.23	0.92	0.73	0.51	0.78	0.8	0.63	0.92	0.64	-0.88
Current Deferred Revenue	-0.71	-0.71	-0.7	-0.48	0.7	-0.68	-0.64		0.19	0.59	-0.73	-0.44	-0.49	-0.64	-0.23	-0.67	0.13	-0.79	-0.51	-0.28	-0.5	-0.57	-0.37	-0.59	-0.69	0.71
Net Debt	-0.4	-0.3	-0.26	-0.82	0.44	-0.59	-0.1	0.19		0.34	-0.31	-0.54	0.02	-0.13	0.16	-0.43	0.41	-0.32	-0.47	0.35	-0.18	-0.46	0.28	-0.29	-0.44	0.37
Retained Earnings	-0.8	-0.86	-0.89	-0.29	0.88	-0.53	-0.88	0.59	0.34		-0.84	-0.83	-0.77	-0.85	-0.18	-0.72	0.49	-0.86	-0.94	-0.55	-0.61	-0.97	-0.65	-0.96	-0.75	0.98
Accounts Payable	0.79	0.94	0.96	0.46	-0.92	0.65	0.93	-0.73	-0.31	-0.84		0.61	0.85	0.92	0.27	0.67	-0.24	0.93	0.71	0.34	0.86	0.79	0.47	0.86	0.72	-0.87
Cash	0.85	0.58	0.64	0.36	-0.78	0.68	0.58	-0.44	-0.54	-0.83	0.61		0.43	0.56	-0.07	0.85	-0.51	0.69	0.81	0.59	0.37	0.84	0.64	0.7	0.85	-0.81
Non Current Assets Total	0.56	0.89	0.91	0.08	-0.79	0.28	0.96	-0.49	0.02	-0.77	0.85	0.43		0.9	0.59	0.4	-0.26	0.79	0.63	0.45	0.78	0.7	0.56	0.88	0.45	-0.77
Non Currrent Assets Other	0.72	0.89	0.91	0.28	-0.9	0.49	0.95	-0.64	-0.13	-0.85	0.92	0.56	0.9		0.34	0.61	-0.27	0.9	0.74	0.45	0.66	0.8	0.57	0.9	0.64	-0.87
Other Assets	0.07	0.51	0.42	-0.05	-0.31	-0.04	0.49	-0.23	0.16	-0.18	0.27	-0.07	0.59	0.34		-0.02	0.06	0.35	0.08	0.06	0.31	0.13	0.13	0.36	-0.01	-0.21
Cash And Short Term Investments	0.98	0.62	0.66	0.55	-0.77	0.91	0.6	-0.67	-0.43	-0.72	0.67	0.85	0.4	0.61	-0.02		-0.25	0.82	0.67	0.55	0.35	0.71	0.61	0.61	1.0	-0.77
Good Will	-0.26	-0.26	-0.26	-0.23	0.4	-0.19	-0.23	0.13	0.41	0.49	-0.24	-0.51	-0.26	-0.27	0.06	-0.25		-0.22	-0.73	-0.05	-0.11	-0.67	-0.09	-0.57	-0.25	0.53
Common Stock Total Equity	0.9	0.95	0.95	0.5	-0.93	0.74	0.92	-0.79	-0.32	-0.86	0.93	0.69	0.79	0.9	0.35	0.82	-0.22		0.75	0.45	0.69	0.82	0.57	0.86	0.85	-0.91
Common Stock Shares Outstanding	0.72	0.75	0.76	0.39	-0.81	0.51	0.73	-0.51	-0.47	-0.94	0.71	0.81	0.63	0.74	0.08	0.67	-0.73	0.75		0.37	0.44	0.99	0.46	0.92	0.68	-0.94
Non Current Liabilities Total	0.57	0.31	0.42	-0.39	-0.42	0.22	0.51	-0.28	0.35	-0.55	0.34	0.59	0.45	0.45	0.06	0.55	-0.05	0.45	0.37		0.22	0.42	0.99	0.42	0.55	-0.48
Other Current Assets	0.51	0.79	0.81	0.28	-0.66	0.41	0.78	-0.5	-0.18	-0.61	0.86	0.37	0.78	0.66	0.31	0.35	-0.11	0.69	0.44	0.22		0.55	0.33	0.67	0.44	-0.62
Other Stockholder Equity	0.78	0.81	0.84	0.4	-0.87	0.57	0.8	-0.57	-0.46	-0.97	0.79	0.84	0.7	0.8	0.13	0.71	-0.67	0.82	0.99	0.42	0.55		0.52	0.95	0.74	-0.97
Total Liab	0.65	0.45	0.55	-0.3	-0.54	0.3	0.63	-0.37	0.28	-0.65	0.47	0.64	0.56	0.57	0.13	0.61	-0.09	0.57	0.46	0.99	0.33	0.52		0.54	0.62	-0.59
Property Plant And Equipment Gross	0.72	0.91	0.92	0.3	-0.89	0.46	0.92	-0.59	-0.29	-0.96	0.86	0.7	0.88	0.9	0.36	0.61	-0.57	0.86	0.92	0.42	0.67	0.95	0.54		0.64	-0.96
Total Current Assets	0.99	0.67	0.71	0.56	-0.8	0.92	0.64	-0.69	-0.44	-0.75	0.72	0.85	0.45	0.64	-0.01	1.0	-0.25	0.85	0.68	0.55	0.44	0.74	0.62	0.64		-0.8
Intangible Assets	-0.85	-0.89	-0.91	-0.41	0.92	-0.64	-0.88	0.71	0.37	0.98	-0.87	-0.81	-0.77	-0.87	-0.21	-0.77	0.53	-0.91	-0.94	-0.48	-0.62	-0.97	-0.59	-0.96	-0.8

Click cells to compare fundamentals

Pulse Biosciences Account Relationship Matchups

Pulse Biosciences fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	41.3M	54.2M	77.9M	59.2M	68.0M	49.9M
Other Current Liab	4.8M	4.4M	2.6M	3.8M	4.4M	2.5M
Total Current Liabilities	7.6M	8.5M	6.0M	6.7M	7.7M	4.4M
Total Stockholder Equity	22.9M	35.7M	(2.2M)	44.4M	51.0M	32.9M
Net Tangible Assets	58.3M	23.4M	16.2M	29.7M	34.1M	26.1M
Property Plant And Equipment Net	11.9M	11.2M	10.0M	8.8M	10.1M	6.1M
Net Debt	(1.1M)	(17.4M)	14.8M	(35.2M)	(31.7M)	(30.1M)
Retained Earnings	(172.5M)	(236.2M)	(294.7M)	(336.9M)	(303.2M)	(288.1M)
Accounts Payable	1.7M	2.9M	1.6M	1.8M	2.1M	1.4M
Cash	12.5M	28.6M	61.1M	44.4M	51.0M	53.6M
Non Current Assets Total	19.0M	17.6M	15.7M	13.8M	15.9M	14.8M
Cash And Short Term Investments	20.5M	28.6M	61.1M	44.4M	51.0M	33.5M
Common Stock Shares Outstanding	23.2M	28.0M	33.9M	48.0M	55.2M	58.0M
Liabilities And Stockholders Equity	41.3M	54.2M	77.9M	59.2M	68.0M	49.9M
Non Current Liabilities Total	10.8M	10.0M	74.1M	8.1M	9.3M	12.6M
Other Current Assets	1.9M	4.3M	1.0M	963K	1.1M	1.2M
Other Stockholder Equity	195.4M	271.9M	292.4M	381.2M	438.4M	460.3M
Total Liab	18.4M	18.6M	80.1M	14.8M	17.0M	17.0M
Property Plant And Equipment Gross	11.9M	11.2M	10.0M	12.3M	14.1M	14.8M
Total Current Assets	22.3M	36.6M	62.1M	45.3M	52.1M	35.1M
Intangible Assets	3.9M	3.2M	2.6M	1.9M	1.7M	1.6M
Common Stock	25K	29K	37K	55K	49.5K	47.0K
Property Plant Equipment	2.2M	7.7M	2.5M	11.2M	12.9M	13.6M
Net Invested Capital	22.9M	36.1M	63.7M	44.4M	39.9M	35.4M
Net Working Capital	14.8M	28.1M	56.2M	38.6M	44.4M	39.8M
Capital Stock	25K	29K	37K	55K	63.3K	34.5K
Short Long Term Debt Total	11.4M	11.3M	76.0M	9.1M	10.5M	10.0M
Capital Lease Obligations	11.4M	10.8M	10.0M	9.1M	10.5M	10.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

When determining whether Pulse Biosciences is a strong investment it is important to analyze Pulse Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulse Biosciences' future performance. For an informed investment choice regarding Pulse Stock, refer to the following important reports:

How To Invest In Pulse

Details

Is Pulse Stock a good investment?

Details

What is Pulse Biosciences' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulse Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.

You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulse Biosciences. If investors know Pulse will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulse Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.82)

Return On Assets

(0.38)

Return On Equity

(0.70)

The market value of Pulse Biosciences is measured differently than its book value, which is the value of Pulse that is recorded on the company's balance sheet. Investors also form their own opinion of Pulse Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pulse Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulse Biosciences' market value can be influenced by many factors that don't directly affect Pulse Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Pulse Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulse Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulse Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Pulse End Period Cash Flow vs Capital Expenditures Analysis

End Period Cash Flow vs Capital Expenditures

End Period Cash Flow vs Capital Expenditures Correlation Analysis

Correlation Coefficient

End Period Cash Flow

Capital Expenditures

Pulse Biosciences fundamental ratios Correlations

Pulse Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pulse Biosciences fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Current Assets	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Other Current Liab
Other Stockholder Equity	+ 0.99	Common Stock Shares Outstanding
Total Liab	+ 0.99	Non Current Liabilities Total
Cash And Short Term Investments	+ 0.98	Total Assets

Intangible Assets	- 0.97	Other Stockholder Equity
Other Stockholder Equity	- 0.97	Retained Earnings
Intangible Assets	- 0.96	Property Plant And Equipment Gross
Property Plant And Equipment Gross	- 0.96	Retained Earnings
Intangible Assets	- 0.94	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.94	Retained Earnings